Scientists Hit 150 Billion 'Jackpot' with NK Cell Technology... Achieving Triple Benefits [Reading Science]

Reference photo. Not related to the article.

[Asia Economy Reporter Kim Bong-su] “Young scientists invent groundbreaking scientific technologies that have a significant impact on humanity. Thanks to this, they hit the 'jackpot' in life, gaining fame and earning enormous amounts of money.”

This is the newly established path to success and fame (立身楊名) since science and technology began to determine the fate of humanity. Many TV dramas and movies feature such people as protagonists. A representative example is the recently popular 'Sisyphus' starring Jo Seung-woo (photo). The protagonist invents time machine technology, becoming a national star while amassing astronomical wealth, living in a magnificent mansion, and driving supercars. People are enthusiastic and wish to live such lives. However, in reality, such 'life jackpots' sometimes do happen.

A recent representative case is the team led by Dr. Choi In-pyo (photo below) at the Immunotherapy Research Center of the Korea Research Institute of Bioscience and Biotechnology, who developed a technology to differentiate and massively proliferate NK (Natural Killer) cells, an autoimmune agent with excellent cancer healing effects derived from hematopoietic stem cells.

NK cells are immune cells that make up about 10% of the human blood immune cells. They are representative anticancer immune cells that kill cancer cells on the front lines without any other stimulation. When administered to cancer patients, they attack cancer cells without self-proliferation and then gradually disappear, causing almost no side effects, unlike other immune cell therapies such as T cells, which have side effects due to self-proliferation. They can also be administered to others.

Thanks to this, treatment costs are reduced, and the effects are excellent. Dr. Choi’s team, in collaboration with Professor Lee Kyu-hyung’s team at Seoul Asan Medical Center, conducted clinical research on patients with intractable leukemia, achieving a patient survival rate of 40%, more than three times that of the control group. It can be used for immunotherapy of intractable leukemia, lung cancer, and is expected to be applied to the treatment of solid tumors (cancers occurring in specific organs) such as lung cancer in the future.

The problem is that mass production of NK cells is difficult. It was challenging to mass-produce them using conventional culturing methods. Consequently, the bio industry is rushing to develop technologies for mass production of NK cells. Recently, GC Green Cross LabCell obtained a patent for a technology that increases NK cell productivity through large-scale culturing using a bioreactor.

With this 'jackpot technology' emerging from the research results of the Korea Research Institute of Bioscience and Biotechnology, the market cheered. The institute recently sold this technology to a private company for a lump sum (fixed technology fee) of 9.5 billion KRW and agreed to receive an additional 145 billion KRW depending on sales, securing a total revenue of 154.5 billion KRW. The NK cell mass production technology will be commercialized after clinical trials within this year, allowing cancer patients to receive effective and affordable treatments.

Of course, this research result is the fruit of public investment, so Dr. Choi’s team cannot claim it all. This research was achieved through long-term stable support from the Immunotherapy (CiM) Convergence Research Group project under the National Science and Technology Research Council (NST) under the Ministry of Science and ICT, national research and development projects by the Ministry of Science and ICT and the Ministry of Health and Welfare, and the Korea Research Institute of Bioscience and Biotechnology’s own projects. Therefore, most of the revenue will be returned to the national treasury, and Dr. Choi’s team is expected to receive only incentives.

How about it? Dr. Choi’s team provided a breakthrough in humanity’s long-standing challenge of overcoming cancer and generated enormous national wealth. They must have earned a decent incentive along with their fame. It’s a triple win. Isn’t it wonderful and proud that they achieved the aspirations they had since childhood, dreaming of becoming scientists?

This content was produced with the assistance of AI translation services.